CSF2 and colorectal carcinoma: Forty patients with HLA-A*0201+CEA+ stage III or IV CRC were either treated with ascites-derived exosomes alone or in conjunction with granulocyte-macrophage colony-stimulating factor (GM-CSF) [84].